Influenza News
| Jul 22, 2008 – SOURCE: DGNews | |||
 |
|
Flu Pandemic May Cripple US Hospitals, Alternate Care Centres Not Prepared | |
| ANN ARBOR, Mich -- July 22, 2008 -- A new study suggests that if an influenza pandemic hits the United States and nursing homes are expected to assist with the patient overflow from hospitals, many are not prepared for the task. The study is published in | |||
| Jul 18, 2008 – SOURCE: Journal of Pediatrics | |||
|
|
Effects of Influenza Plus Pneumococcal Conjugate Vaccination Versus Influenza Vaccination Alone in Preventing Respiratory Tract Infections in Children: A Randomized, Double-Blind, Placebo-Controlled Trial | |
| OBJECTIVE: To evaluate the effects of influenza vaccination with or without heptavalent pneumococcal conjugate vaccination on respiratory tract infections (RTIs) in children. STUDY DESIGN: This was a randomized, double-blind, placebo-controlled trial comp | |||
| Jul 17, 2008 – SOURCE: International Journal of Cardiology | |||
|
|
Cardiovascular manifestations associated with influenza virus infection | |
| Influenza accounts for 3 to 5 million cases of severe illness and up to 300,000 deaths annually. Cardiovascular involvement in acute influenza infection can occur through direct effects of the virus on the myocardium or through exacerbation of existing ca | |||
| Jul 17, 2008 – SOURCE: DGNews | |||
|
|
Booster Shot May Help Control Future Avian Influenza Pandemic | |
| CHICAGO -- July 17, 2008 -- A booster vaccination against H5N1 avian influenza given years after initial vaccination, with a different strain, may prove useful in controlling a potential future pandemic, according to a study published in the August 1 issu | |||
| Jul 17, 2008 – SOURCE: Annals of the Rheumatic Diseases (ARD Online) | |||
|
|
Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination | |
| OBJECTIVES: Wegener's granulomatosis (WG) is a systemic vasculitis characterized by relapsing and remitting disease activity. Immunosuppressive drugs are used to control disease, but increase susceptibility to infection. Therefore, influenza vaccination s | |||
| Jul 11, 2008 – SOURCE: Vaccine | |||
|
|
Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age | |
| Three pivotal trials supported the licensure of live attenuated influenza vaccine (LAIV) for children>/=2 years of age: 2 placebo-controlled studies each conducted over 2 seasons, and a 1-year trial comparing LAIV with trivalent inactivated influenza vacc | |||
| Jul 9, 2008 – SOURCE: Vaccine | |||
|
|
Seasonal inactivated influenza virus vaccines | |
| Inactivated influenza virus vaccines are the primary modality used for prevention of influenza. A system of annual identification of new strains causing illnesses, selections for vaccines, chick embryo growth, inactivation, processing, packaging, distribu | |||
| Jul 9, 2008 – SOURCE: Vaccine | |||
|
|
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine | |
| To augment the available influenza vaccine supply, a phase III study was conducted to evaluate the immunogenicity, safety, and consistency of a new trivalent inactivated influenza vaccine manufactured by CSL Limited. Healthy adults (ages 18-64) were rando | |||
| Jul 9, 2008 – SOURCE: Vaccine | |||
|
|
Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals | |
| A randomized double-blind placebo-controlled study was conducted to determine the effect of sublingual administration of IFNalpha on the immune response to influenza vaccination in elderly institutionalized individuals. Sublingual administration of 10 mil | |||
| Jul 9, 2008 – SOURCE: Vaccine | |||
|
|
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China | |
| The burden of influenza is well known in the elderly and at-risk patients, but also in children. Especially in those under 5 years old, influenza may cause severe morbidity and mortality. Influenza infections and complications can be reduced by vaccinatio | |||
